Dr. Jeremy Weate
CEO & Director
Jeremy has over 17 years strategic advisory experience, focused on minister-level guidance on the mining sector across over 50 projects in over 30 countries in Europe, Africa, Central Asia and the South Pacific. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti. In 2018, he helped set up Tabula Rasa Retreat in Portugal, now one of the leading ibogaine treatment facilities in the world. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK.
Chairman, Founder & Director
Shayne Nyquvest is the former Executive Vice President of Mackie Research Capital and a founding member of the Canaccord Genuity Group. Nyquvest can personally vouch for the transformational effects of ibogaine and aims to see this treatment adopted by the mainstream medical community as an answer to the opioid epidemic.
Director of Operations
Richard Avis is a senior management executive with a 30-year strong background in start-up management and franchising. He most recently operated a Vancouver-based advisory firm specializing in the growth & profitability of Startups, SMB’s, Emerging Brands and Franchised operations, including leadership mentoring, brand management, franchise compliance & marketing.
Greg Leavens, CFO
Greg Leavens, CPA CA - a Calgary based financial executive (past CFO and Controller roles) with 30 years experience in public accounting and industry, including the oil & gas exploration / production and service sectors. Greg started his career with KPMG, and has extensive experience in leadership, strategic planning, due diligence reviews, financing, forecasting, financial reporting, treasury and risk management, and regulatory compliance. His background includes significant roles in planning, monitoring, and executing programs to aid in achieving high profitability, growth, and success of results oriented management teams, especially in start-up, entrepreneurial environments.
Chief Nursing Advisor
Hirpal has over 30 years of health care leadership experience focused on clinical practice in high acuity settings, curriculum development and delivery for registered nurses and regularly serves the Supreme Court of B.C. as an expert on standard of care. Hirpal has worked closely with Health Canada to facilitate upcoming clinical trials for ibogaine in Canada. Hirpal is a graduate the University of British Columbia with her Master of Science in Nursing (Hons) and is certified by the Canadian Patient Safety Institute. Her recent research on critical thinking in the face of complexity has been internationally recognized. Hirpal is committed to developing more comprehensive and holistic systems of care for those suffering from addiction.
Colleen Clandening utilizes her passion to give back and her expertise in business development. A true visionary and entrepreneur. Colleen upholds the core value of “shared leadership” throughout her career. She is the CEO of Zane David Enterprises Inc. (ZDE) and former CEO of eScape MovieWorks Inc. Colleen works internationally across different sectors; entertainment, design build, retail, manufacturing, real estate, government, and non-profits. She loves her family, sharing stories with friends, laughter, vulnerability and horses. She is committed to fitness…physical, mental and spiritual.
Dr. Sue Nielsen
After many years of study, practicing yoga and meditation, and with spiritual guidance, I found a unique path to recovery. I uncovered a little-known psychedelic called Ibogaine. It reduces opioid withdrawals from weeks to months down to mere hours. It supports psychological healing. It helps the post-withdrawal period to minimize depression and relapse. After gaining back my freedom from opioid dependence, I wanted to share my experience with the rest of the world. Ibogaine represents a positive benefit in the battle against the opioid pandemic and warrants further investigation.
Frank Albo, PhD
Dr. Frank Albo is an internationally recognized historian and a leading authority on coded language systems in art and architecture. He holds a PhD and MPhil in the history of architecture from the University of Cambridge; an MA in ancient Near Eastern languages and culture from the University of Toronto; and a BA in religious studies and anthropology from the University of Winnipeg. A two-time bestselling author, Dr. Albo has acted as a consultant for the government of Kazakhstan, the Prince’s Regeneration Trust in the UK., as well as the world's leading design firms, including Foster + Partners, BuroHappold, and Thinc Design. Dr. Albo currently doubles as a visiting professor at the universities of Winnipeg and Manitoba, where he focuses on prehistoric Indigenous studies.
Dr. Alberto Sola
MD, Co-Founder & Director
Clear Sky Addiction Solution’s President, Dr Sola is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Universidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals for tourists in Puerto Vallarta, Cancun, and Cabo San Lucas.
Chief Ian Campbell, Director
Chief Ian Campbell is a hereditary chief of the Squamish Nation located in Vancouver, British Columbia. He has served as an elected member of council since 2005, and was appointed as a Political Spokesperson in 2008. Since 1999 he has been the Cultural Ambassador and Negotiator for the Intergovernmental Relations Department of the Squamish Nation, advancing Aboriginal rights and title, while invigorating substantive economic opportunities through negotiations, collaboration, and partnerships.
Robert Turner, Director
Mr. Turner is President of his own incorporated consulting firm and a Principal within Western Management Consultants (WMC). His consulting focus is providing guidance to Boards on their governance including proper CEO oversight. Mr. Turner brings experience as a CHRO in both the private and public sectors. Subsequently, he joined Mercer Canada as a Partner focused on consulting within Canadian health care. Robert has served on Universal Ibogaine’s Advisory Board since December 2019. Robert has an ICD.D certification from Rotman Business School, an MBA from the Ivey Business School and a BSc (Biochemistry) from the University of Toronto. He serves on the Boards of two other corporations – one private and one not-for-profit.